Innovatia

Australia, while the company’s Healthcare divi- sion provides oncology, neurology and fertility treatments to patients around the country. In 2021, Merck strengthened and expanded its commitment to diversity. While Merck has always been a diverse organisation, it recog- nises that its success depends on its ability to

foster an environment that promotes equity and cultivates inclusion. This approach is evident globally, with more than 36% of leadership roles held by women, and locally, with Josie Downey at the helm as General Manager and Managing Director of Merck Healthcare ANZ and Rebecca Lee as Head of Science and Laboratory Solutions and Managing Director of Merck Life Science ANZ. Mobilising Merck’s might to fight the pandemic Merck’s commitment to supporting human progress was clearly demonstrated in the or- ganisation’s response to COVID-19. “During these difficult times, Merck stepped up and was fully dedicated to actively contrib- uting its substantial resources and significant expertise to fight what has become the biggest health crisis of the last 100 years, drawing upon its global scale and breadth of experience and talent to help humanity battle the disease”, says Josie. Merck’s contribution to the pandemic’s re- sponse includes product and service sup- port for 80 Vaccine manufacturers, the use of Merck’s raw materials and services for over 35 COVID-19 test systems, while more than 50 Monoclonal antibodies, plasma products and antiviral drugs rely on resources and intellec- tual property provided by Merck. In October 2020, the Australian Government announced it had contracted CSL Behring Aus- tralia to manufacture approximately 50 million doses of COVID-19 vaccines in Australia for sup- ply to the country, the first doses of which were rolled out in March 2021. Merck’s teams collab- orated closely with CSL to ensure the vaccine,

INNOVATING FOR THE GREATER GOOD, INVENTING FOR A HEALTHIER HUMANITY

Harnessing the power of leading- edge science to save and improve lives around the world, Merck ANZ is helping humanity meet the challenges of today and prepare for the challenges of tomorrow. W ith more than 60,000 employees across 66 countries worldwide, Ger- man multinational science and tech- nology company, Merck Group, is divided into three streams: Healthcare, Life Sciences and Electronics. Founded in 1668, Merck is the world’s oldest operating chemical and phar- maceutical company. For more than three and a half centuries, Merck’s unwavering commitment to ongoing scientific exploration and responsible entre- preneurship have been key to the company’s long list of achievements in technological and scientific advancement, providing a solid eth- ical foundation from which it has consistently been able to innovate, invent, expand, and evolve. Locally, Merck ANZ employs over 250 people within Australia and New Zealand, Merck Life Science provides over 100,000 different prod- ucts to all of the leading universities, research institutes and biotechnology companies in

INNOVATIA

230

INNOVATIA

| Science

231